CEO of Therapeuticsmd Inc (30-Year Financial, Insider Trades) Robert G Finizio (insider trades) bought 72,000 shares of TXMD on 10/25/2019 at an average price of $2.75 a share. The total cost of this purchase was $198,000.
TherapeuticsMD Inc is a women's health care company focused on creating and commercializing products targeted exclusively for women. It is engaged in pre-commercialization activities for advanced hormone therapy pharmaceutical product. TherapeuticsMD Inc has a market cap of $699.550 million; its shares were traded at around $2.90 with and P/S ratio of 37.66. TherapeuticsMD Inc had annual average EBITDA growth of 30.00% over the past ten years. GuruFocus has detected 6 severe warning signs with TherapeuticsMD Inc. .
CEO Recent Trades:
- CEO Robert G Finizio bought 72,000 shares of TXMD stock on 10/25/2019 at the average price of $2.75. The price of the stock has increased by 5.45% since.
Directors and Officers Recent Trades:
- President/Secretary John C.k. Iv Milligan bought 72,000 shares of TXMD stock on 10/25/2019 at the average price of $2.75. The price of the stock has increased by 5.45% since.
- Director Brian Bernick bought 36,000 shares of TXMD stock on 10/25/2019 at the average price of $2.75. The price of the stock has increased by 5.45% since.
For the complete insider trading history of TXMD, click here
.
